88 results
Page 2 of 5
8-K
EX-1.1
yxq34k5k0ukeej 6al
24 Feb 21
PAVmed Announces Proposed Public Offering of Common Stock
5:27pm
424B5
oo1pq91c
24 Feb 21
Prospectus supplement for primary offering
5:26pm
424B5
okuctmx xw
22 Feb 21
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
mij9xuv66o
6 Jan 21
PAVmed Announces Registered Direct Offering of its Common Stock Priced At-the-Market under Nasdaq Rules
9:30am
8-K
EX-1.1
ssp1m sqtws
18 Dec 20
PAVmed Announces Pricing of Additional $8.1 Million Common Stock Registered Direct Offering
9:29am
8-K
EX-1.1
lkw37kro7rsgo2hh
11 Dec 20
PAVmed Announces Registered Direct Offering of its Common Stock
10:26am
D
cru0d58vgpux2
11 Aug 20
$7.75M in debt / options / securities to be acquired, sold $7.75M, 1 investor
2:49pm
8-K
EX-10.1
xd4wqh9477
6 Aug 20
Entry into a Material Definitive Agreement
9:27am
8-K
EX-10.3
26m6ifuf5chtea
6 Aug 20
Entry into a Material Definitive Agreement
9:27am
8-K
EX-10.2
sn40 452mjgbwy
6 Aug 20
Entry into a Material Definitive Agreement
9:27am
8-K
EX-10.4
5xp ge4nn
6 Aug 20
Entry into a Material Definitive Agreement
9:27am
D
89cdxu
1 May 20
$4.11M in debt / options / securities to be acquired, sold $4.11M, 1 investor
4:31pm
8-K
EX-10.2
ru6yh0vxyxwaik
1 May 20
Entry into a Material Definitive Agreement
9:25am